BSEBoard Meeting5h ago · 22 Jul 2026, 11:51 am

Epigral Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2026 ,inter alia, to consider and approve Un-audited Financial Results (Standalone ....

Epigral Ltd · 543332

✦ AI SummaryResults

Epigral Ltd has scheduled a board meeting on 27th July 2026 to consider un-audited financial results for the first quarter ended 30th June 2026 and to take on record the limited review report of the statutory auditors.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Epigral Ltd - 543332 - Board Meeting Intimation for Intimation Of The Board Meeting Of Epigral Limited Scheduled To Be Held On Monday, 27Th July, 2026.

Attachments (1)

📄

686f881c-84e8-4966-b496-b3806eff4583.pdf

pdf

Download →
View document text
22.07.2026 National Stock Exchange of India Limited BSE Limited “Exchange Plaza”, Floor- 25, P J Tower, Bandra-Kurla Complex, Dalal Street, Bandra (East) Mumbai 400 051 Mumbai 400 001 SYMBOL:- EPIGRAL Scrip Code: 543332 Dear Sirs, Sub.: Intimation of the Board Meeting of Epigral Limited scheduled to be held on Monday, 27th July, 2026. Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the meeting of the Board of Directors of the Company will be held on Monday, 27th July, 2026, at the Registered Office of the Company, inter-alia to consider: 1. Un-audited Financial Results (Standalone & Consolidated) of the Company for the First Quarter ended on 30th June, 2026 and to take on record the Limited Review Report of the Statutory Auditors thereon; and 2. Any other business with the permission of the Chair. The intimation is being given for the information of Shareholders / Members. Thanking you, Yours faithfully, For Epigral Limited Gaurang Trivedi Company Secretary & Compliance Officer M. No. A22307